William F. Daniel's Insider Trades & SAST Disclosures
William F. Daniel's most recent trade in Horizon Therapeutics Plc was a trade of 3,913 Ordinary Shares done . Disclosure was reported to the exchange on April 28, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern William F. Daniel.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Horizon Therapeutics Plc
|
William F. Daniel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 3,913 | 33,794 (0%) | 0% | - | Ordinary Shares | |
|
Horizon Therapeutics Plc
|
William F. Daniel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2023 | 3,913 | 0 | - | - | Restricted Stock Units | |
|
Horizon Therapeutics Plc
|
William F. Daniel | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 111.16 per share. | 28 Apr 2023 | 1,879 | 31,915 (0%) | 0% | 111.2 | 208,870 | Ordinary Shares |
|
Horizon Therapeutics Plc
|
William F. Daniel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 4,223 | 78,690 (0%) | 0% | - | Ordinary Shares | |
|
Horizon Therapeutics Plc
|
William F. Daniel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Apr 2022 | 4,223 | 0 | - | - | Restricted Stock Units | |
|
Horizon Therapeutics Plc
|
William F. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Apr 2022 | 3,913 | 3,913 | - | - | Restricted Stock Units | |
|
Horizon Therapeutics Plc
|
William F. Daniel | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 98.56 per share. | 28 Apr 2022 | 1,139 | 77,551 (0%) | 0% | 98.6 | 112,260 | Ordinary Shares |
|
Horizon Therapeutics Plc
|
William F. Daniel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.70 per share. | 10 May 2021 | 20,000 | 20,000 (0%) | 0% | 12.7 | 254,000 | Common Stock |
|
Horizon Therapeutics Plc
|
William F. Daniel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 May 2021 | 20,000 | 13,286 | - | - | Stock Option (Right to Buy) | |
|
Horizon Therapeutics Plc
|
William F. Daniel | Director | Sale of securities on an exchange or to another person at price $ 86.56 per share. | 10 May 2021 | 19,834 | 166 (0%) | 0% | 86.6 | 1,716,831 | Common Stock |
|
Horizon Therapeutics Plc
|
William F. Daniel | Director | Sale of securities on an exchange or to another person at price $ 87.01 per share. | 10 May 2021 | 166 | 0 (0%) | 0% | 87.0 | 14,444 | Common Stock |
|
Horizon Therapeutics Plc
|
William F. Daniel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 11,098 | 77,460 (0%) | 0% | - | Ordinary Shares | |
|
Horizon Therapeutics Plc
|
William F. Daniel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2021 | 11,098 | 0 | - | - | Restricted Stock Units | |
|
Horizon Therapeutics Plc
|
William F. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2021 | 4,223 | 4,223 | - | - | Restricted Stock Units | |
|
Horizon Therapeutics Plc
|
William F. Daniel | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 94.62 per share. | 29 Apr 2021 | 2,993 | 74,467 (0%) | 0% | 94.6 | 283,198 | Ordinary Shares |
|
Horizon Therapeutics Plc
|
William F. Daniel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2020 | 15,390 | 70,513 (0%) | 0% | - | Ordinary Shares | |
|
Horizon Therapeutics Plc
|
William F. Daniel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2020 | 15,390 | 0 | - | - | Restricted Stock Units | |
|
Horizon Therapeutics Plc
|
William F. Daniel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2020 | 11,098 | 11,098 | - | - | Restricted Stock Units | |
|
Horizon Therapeutics Plc
|
William F. Daniel | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 35.62 per share. | 30 Apr 2020 | 4,151 | 66,362 (0%) | 0% | 35.6 | 147,859 | Ordinary Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges